ND2 EVALUATIONS OF THE PRESCRIBED DAILY DOSES OF TRANSDERMAL FENTANYL AND TRANSDERMAL BUPRENORPHINE IN CANCERAND NON-CANCER PATIENTS IN GERMANY- RESULTS FROM A RETROSPECTIVE DATABASE ANALYSIS
May 1, 2006, 00:00
10.1016/S1098-3015(10)64379-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)64379-3/fulltext
Title :
ND2 EVALUATIONS OF THE PRESCRIBED DAILY DOSES OF TRANSDERMAL FENTANYL AND TRANSDERMAL BUPRENORPHINE IN CANCERAND NON-CANCER PATIENTS IN GERMANY- RESULTS FROM A RETROSPECTIVE DATABASE ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64379-3&doi=10.1016/S1098-3015(10)64379-3
First page :
Section Title :
Open access? :
No
Section Order :
280